Ibuflam Lichtenstein

Ibuprofen, the active ingredient in Ibuflam Lichtenstein, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is used to relieve mild to moderate pain, reduce fever, and manage inflammatory conditions such as arthritis.

GNH USA supplies Ibuflam Lichtenstein as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory compliance across multiple markets.

Ibuflam Lichtenstein (ibuprofen) acts on prostaglandin‑mediated pathways to provide analgesic, antipyretic and anti‑inflammatory effects.

- Mild to moderate pain: effective relief of headache, dental, musculoskeletal and menstrual discomfort. - Fever: reduction of elevated body temperature in acute and chronic febrile states. - Osteoarthritis: alleviation of joint pain and improvement of functional mobility. - Rheumatoid arthritis: decrease of inflammatory joint swelling and stiffness. - Dysmenorrhea: mitigation of menstrual cramps and associated pain.

Ibuflam Lichtenstein may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo: transient sensations of light‑headedness. - Rash or mild skin irritation: localized erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: severe abdominal pain or black stools. - Renal impairment: reduced urine output or swelling. - Hepatotoxicity: jaundice or elevated liver enzymes. - Severe hypersensitivity reactions: anaphylaxis, angioedema or bronchospasm.

Before using Ibuflam Lichtenstein, consider the following precautions to minimize risk.

- Cardiovascular risk: avoid use in patients with established coronary artery disease unless advised. - Gastrointestinal history: assess for ulcers or bleeding disorders prior to therapy. - Renal function: monitor kidney status in patients with chronic kidney disease. - Concomitant NSAIDs or anticoagulants: increase risk of bleeding; use with caution. - Pregnancy and lactation: consult healthcare professional before use. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Ibuprofen can interact with several medicines; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): heightened bleeding risk. - High‑dose aspirin: increased gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): potential for bleeding complications. - ACE inhibitors or ARBs in volume‑depleted patients: may reduce renal function. - Lithium: ibuprofen can raise lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in antihypertensive effect. - Methotrexate: decreased renal clearance leading to toxicity. - Cyclosporine: increased nephrotoxic risk. - Corticosteroids: additive gastrointestinal ulcer risk. - Antidiabetic agents: may affect glycemic control.